Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Exosome Market Trends and Forecast
3.3: Global Exosome Market by Product & Service
3.3.1: Kits & Reagents
3.3.2: Instruments
3.3.3: Services
3.4: Global Exosome Market by Application
3.4.1: Cancer Applications
3.4.1.1: Lung Cancer
3.4.1.2: Breast Cancer
3.4.1.3: Prostate Cancer
3.4.1.4: Colorectal Cancer
3.4.1.5: Other Cancers
3.4.2: Non-Cancer Applications
3.5: Global Exosome Market by End User
3.5.1: Academic & Research Institutes
3.5.2: Pharmaceutical & Biotechnology Companies
3.5.3: Hospitals & Clinical Testing Laboratories
3.6: Global Exosome Market by Workflow
3.6.1: Isolation Methods
3.6.1.1: Ultracentrifugation
3.6.1.2: Immunocapture on beads
3.6.1.3: Precipitation
3.6.1.4: Filtration
3.6.2: Downstream Analysis
3.6.2.1: Cell Surface Marker Analysis using Flow Cytometry
3.6.2.2: Protein Analysis using Blotting & ELISA
3.6.2.3: RNA Analysis with NGS & PCR
3.6.2.4: Proteomic Analysis using Mass Spectrometry
3.6.2.5: Others
3.7: Global Exosome Market by Biomolecule Type
3.7.1: Non-Coding RNAs
3.7.2: mRNA
3.7.3: Proteins/Peptides
3.7.4: DNA Fragments
3.7.5: Lipids
4. Market Trends and Forecast Analysis by Region
4.1: Global Exosome Market by Region
4.2: North American Exosome Market
4.2.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.2.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.2.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.2.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.2.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.2.6: The United States Exosome Market
4.2.7: The Canadian Exosome Market
4.2.8: The Mexican Exosome Market
4.3: European Exosome Market
4.3.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.3.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.3.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.3.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.3.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.3.6: The German Exosome Market
4.3.7: The United Kingdom Exosome Market
4.3.8: The Spain Exosome Market
4.3.9: The Italy Exosome Market
4.3.10: The French Exosome Market
4.4: APAC Exosome Market
4.4.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.4.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.4.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.4.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.4.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.4.6: The Chinese Exosome Market
4.4.7: The Indian Exosome Market
4.4.8: The Japanese Exosome Market
4.5: ROW Exosome Market
4.5.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.5.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.5.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.5.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.5.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.5.5: Brazilian Exosome Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Exosome Market by Product & Service
7.1.2: Growth Opportunities for the Global Exosome Market by Application
7.1.3: Growth Opportunities for the Global Exosome Market by End User
7.1.4: Growth Opportunities for the Global Exosome Market by Workflow
7.1.5: Growth Opportunities for the Global Exosome Market by Biomolecule Type
7.1.6: Growth Opportunities for the Global Exosome Market by Region
7.2: Emerging Trends in the Global Exosome Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Exosome Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Exosome Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: Thermo Fisher Scientific Inc.
8.2: QIAGEN N.V.
8.3: Bio-Techne
8.4: Company 4
8.5: Company 5
8.6: Company 6
8.7: Company 7
8.8: Company 8
8.9: Company 9
8.10: Company 10